• $4.1M
    Market Cap
  • -11.01%
    1-Year Change
  • Medical Instruments & Supplies
    Industry
Annual
Quarterly
12/31/2023
12/31/2022
12/31/2021
Income Statement
Total Operating Revenue
1.1M
-47.08%
2.0M
-27.48%
2.8M
N/A
Cost of Revenue
483,733
-41.16%
822,147
-7.00%
884,066
N/A
Gross Profit
596,421
-51.08%
1.2M
-36.85%
1.9M
N/A
Sales and Marketing Expense
45,826
-40.73%
77,311
+251.88%
21,971
N/A
Research and Development Expense
-29,542
-59.77%
-73,425
+25.86%
-58,340
N/A
Depreciation and Amortization Expense
61,494
+9.38%
56,218
N/A
0
N/A
Total Operating Expenses
1.1M
-5.79%
1.1M
+2.38%
1.1M
N/A
Operating Profit
-467,278
-618.63%
90,098
-89.12%
827,800
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
8,562
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-458,716
-609.13%
90,098
-90.41%
939,065
N/A
Income Taxes
312
-55.56%
702
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-459,028
-613.48%
89,396
-90.48%
939,065
N/A
Net Income from Continuing Operations Applicable to Common
-458,716
-609.13%
90,098
-90.41%
939,065
N/A
Basic EPS and Net Income
-0.01
N/A
0.00
-100.00%
0.01
N/A
Diluted EPS and Net Income
-0.01
N/A
0.00
-100.00%
0.01
N/A
Basic Weighted Average Shares
85.2M
+0.27%
85.0M
+0.30%
84.7M
N/A
Diluted Weighted Average Shares
85.2M
-0.26%
85.4M
+0.83%
84.7M
N/A
Balance Sheet
Cash and Cash Equivalents
1.3M
-7.52%
1.4M
-6.24%
1.5M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.3M
-7.52%
1.4M
-6.24%
1.5M
N/A
Total Current Assets
2.4M
+1.77%
2.3M
+1.02%
2.3M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
158,003
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
173,583
N/A
Total Assets
2.7M
+9.10%
2.4M
-1.32%
2.5M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
0
N/A
0
N/A
Total Current Liabilities
596,366
+298.66%
149,592
-38.15%
241,849
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
179,963
+213.56%
57,393
0.00%
57,393
N/A
Total Liabilities
776,329
+418.96%
149,592
-50.01%
299,242
N/A
Retained Earnings
-19.3M
+2.44%
-18.8M
-0.47%
-18.9M
N/A
Total Stockholders Equity
1.9M
-17.59%
2.3M
+5.36%
2.2M
N/A
Total Shares Outstanding
85.7M
+0.53%
85.2M
+0.26%
85.0M
N/A
Cash Flow
Cash from Operating Activities
-103,976
+13.02%
-91,997
-111.07%
831,382
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
N/A
N/A
N/A
N/A
N/A
N/A
Financials Ratio
Gross Margin
55.22%
-7.55%
59.72%
N/A
N/A
N/A
Operating Margin
-43.26%
-1,080.11%
4.41%
N/A
N/A
N/A
Return on Assets
-17.95%
-594.41%
3.63%
N/A
N/A
N/A
Return on Equity
-21.91%
-648.67%
3.99%
N/A
N/A
N/A
Revenue Growth
-47.08%
+71.36%
-27.48%
N/A
N/A
N/A
Current Ratio
3.97
-74.47%
15.57
N/A
N/A
N/A
Cash Ratio
2.14
-76.80%
9.24
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow